Guest Blogger: RAAFT 2 Trial Summary May 19, 2012
Posted by Heart Rhythm Society in Atrial Fibrillation (AF), Science & Research, Scientific Sessions.Tags: Afib, Atrial fibrillation, RAAFT 2 Trial
add a comment
Editor’s Note: Guest blogger Aman Chugh, MD provides a summary of the RAAFT 2 trial results, which were presented at the Heart Rhythm Society’s 33rd Annual Scientific Sessions in Boston.
Catheter ablation of symptomatic paroxysmal atrial fibrillation (AF) is a class I indication in a patient who has not responded to or has not tolerated medical therapy with an antiarrhythmic medication. However, antiarrhythmic medications are limited by not only modest efficacy but also by significant adverse effects. (more…)
Heart Rhythm 2012: MRI Interaction with Pacers and ICDs May 10, 2012
Posted by Thomas F. Deering, MD, FHRS in Cardiac Rhythm Management, Science & Research, Scientific Sessions.Tags: Heart Rhythm 2012, ICD, Implantable Cardioverter Defibrillator, MagnaSafe Registry
add a comment
Dr. Robert Russo and colleagues presented interim data on 454 patients enrolled in the multi-center (12 sites) MagnaSafe Registry on Wednesday at Heart Rhythm 2012, the 33rd Annual Scientific Sessions of the Heart Rhythm Society in Boston, MA. This study was designed to assess the safety of performing a non-thoracic MRI of 1.5T in pacer patients and non-pacer-dependent implantable cardioverter defibrillator (ICD) patients utilizing a standard management protocol. (more…)
Guest Blogger: ACC.12 Late-Breaking Clinical Trial Review, ISSUE 3 April 12, 2012
Posted by Heart Rhythm Society in Allied Health Professionals, EP Physicians, Science & Research.Tags: Clinical trial
add a comment
Editor’s Note: Guest blogger Kenneth Ellenbogen, MD, FHRS shares his thoughts on a late-breaking clinical trial presented at the American College of Cardiology’s 2012 Annual Scientific Sessions.
For the electrophysiology community, the biggest treat of the American College of Cardiology’s Annual Scientific Sessions was the Pacemaker Therapy in Patients with Neurally-mediated Syncope and Documented Asystole late-breaking clinical trial, presented by Dr. Michele Brignole on behalf of the ISSUE-3 investigators. (more…)
EP News, Basic and Translational April 5, 2012
Posted by Peng-Sheng Chen, MD, FHRS in Science & Research.Tags: Afib, Atrial fibrillation, Ventricular arrhythmia
add a comment
Circadian Variation of Ion Channel Expression
The susceptibility to ventricular arrhythmia or sudden death is determined by the duration (e.g. short or long QT syndromes and heart failure) or pattern (e.g. Brugada syndrome) of ventricular repolarization. It is also known that there is circadian variation of the susceptibility to ventricular arrhythmias. However, the molecular mechanism by which the body’s diurnal biological clock controls the circadian variations of repolarization remains unknown. (more…)
EP Science: Basic and Translational March 14, 2012
Posted by Peng-Sheng Chen, MD, FHRS in Science & Research.Tags: cardiomyopathy
add a comment
Truncation of Titin Causing Dilated Cardiomyopathy
Patients with dilated cardiomyopathy are at high risk of ventricular arrhythmia and sudden cardiac death. According to the Heart Rhythm Society Consensus Statement in Genetic Testing (Ackerman et al, Heart Rhythm 2011; 8:1308), none of the >25 known disease-associated genes has been shown to account for ≥5% of this disease.
A recent article by Herman et al (NEJM 2012; 366:619; PMID: 22335739) is likely to change that statement. The authors analyzed TTN (the gene encoding the sarcomere protein titin) in 312 subjects with dilated cardiomyopathy, 231 subjects with hypertrophic cardiomyopathy, and 249 controls. (more…)
EP Science and Research: Basic and Translational February 16, 2012
Posted by Peng-Sheng Chen, MD, FHRS in Science & Research.Tags: Arrhythmias, ICD, Implantable Cardioverter Defibrillator, sudden infant death syndrome
add a comment
Connexin and arrhythmias
Igarashi et al (Circulation 2012;125:216; PMID 22158756) randomized 30 Yorkshire swine into two groups (sinus rhythm and AF), and each group into three subgroups: sham-operated control, gene therapy with adenovirus expressing connexin (Cx) 40, and gene therapy with adenovirus expressing Cx43. The AF group had burst atrial pacing. All animals underwent terminal study seven days after gene transfer. Sinus rhythm animals had strong transgene expression but no atrial conduction changes. In AF animals, controls had reduced and lateralized Cx43 expression, and Cx43 gene transfer restored expression and cellular location to sinus rhythm control levels. In the AF group, both Cx40 and Cx43 gene transfer improved conduction and reduced AF relative to controls.
The authors conclude that Connexin gene therapy preserved atrial conduction and prevented AF. (more…)
Guest Blogger: Boston AF Symposium Highlights January 27, 2012
Posted by Heart Rhythm Society in Atrial Fibrillation (AF), Science & Research.Tags: AF, Afib, Atrial fibrillation, clinical guidelines
add a comment
Editor’s Note: Guest blogger Hugh Calkins, MD, FHRS, CCDS is the Heart Rhythm Scientific Sessions Program Committee Chair (2012). He provides a brief overview of the Boston AF Symposium, which took place January 12 – 14, 2012.
This year’s Boston AF Symposium was very well attended, with more than 1,200 participants. I would like to share a few highlights from the meeting: (more…)
EP News: Basic and Translational January 10, 2012
Posted by Peng-Sheng Chen, MD, FHRS in Science & Research.Tags: Arrhythmia, Atrial fibrillation, Genetic testing
add a comment
Genetic Testing as a Class I Indication for Patient Care
Gersh et al (Circulation 2011;13:124, PMID 22068435) updated the ACCF/AHA Guideline for the Diagnosis and treatment of Hypertrophic Cardiomyopathy (HCM).
In this updated recommendation for HCM, genetic testing is listed as a Class I recommendation to evaluate patients with HCM. All patients who undergo genetic testing should also undergo genetic counseling. Genetic screening is recommended in first-degree relatives of patients with HCM. In addition, genetic testing is recommended for patients with an atypical clinical presentation of HCM or when another genetic condition is suspected to be the cause. However, the Task Force also played down the importance of using specific mutations to predict the likelihood of sudden cardiac death (SCD). While some earlier works found certain mutations are “malignant,” subsequent studies showed in some instances the rate of adverse events (and prevalence of associated SCD risk markers) was lower in patients with “malignant” mutations than it was in those with mutations believed to be “benign.” (more…)
American Heart Association Meeting Report December 5, 2011
Posted by Peng-Sheng Chen, MD, FHRS in Science & Research.Tags: cardiac arrhythmia, Ventricular arrhythmia, Ventricular fibrillation
1 comment so far
Stellate Ganglionitis and Ventricular Arrhythmia
During the American Heart Association Annual Meeting, Rizzo et al (Circulation 2011:124:A13059) reported pathological characteristics of stellate ganglia resected from five long QT syndrome (LQTS) and five catecholaminergic polymorphic ventricular tachycardia (CPVT) patients. (more…)
EP News: Basic and Translational November 14, 2011
Posted by Peng-Sheng Chen, MD, FHRS in Science & Research.Tags: Cardiac electrophysiology, Research, Science
add a comment
Acetylcholine-Synthesizing T Cells Relay Neural Signals in a Vagus Nerve Circuit
Neural circuits regulate cytokine production to prevent potentially damaging inflammation. A prototypical vagus nerve circuit, the inflammatory reflex, inhibits tumor necrosis factor-α production in spleen by a mechanism requiring acetylcholine signaling through the α7 nicotinic acetylcholine receptor expressed on cytokine-producing macrophages. Nerve fibers in spleen lack the enzymatic machinery necessary for acetylcholine production; therefore, how does this neural circuit terminate in cholinergic signaling? (more…)
Heart Rhythm Society
Laurie Racenet, RN, MSN, ANP
Michael Giudici, MD, FACC, FACP, FHRS
Heather M. Ross, DNP, ANP-BC, CCDS, CEPS, FHRS
Anne Dubin, MD, FHRS
John D. Day, MD, FHRS
Andrea M. Russo, MD, FACC, FHRS
Joshua M. Cooper, MD, FACC
Amit J. Shanker, MD, FHRS, FACC
Bruce Stambler, MD
David Wiggins, RN, BS BME, CEPS
Fred M. Kusumoto, MD, FHRS
Leonard Ganz, MD, FHRS
christinechiuman
Craig Delaughter, MD, PhD
Ariana Del Negro, Heart Rhythm 2010 Quality
Peng-Sheng Chen, MD, FHRS
MSKremers MD,FHRS
Ann C. Garlitski, MD, FACC, FHRS
Alan Cheng, MD, FHRS
Ulrika Birgersdotter-Green, MD
Christopher Clyne, MD, FHRS
Kathleen Blake, MD, MPH, FHRS
David Scher, MD, FHRS
Sanjay Deshpande, MD, FHRS
Thomas F. Deering, MD, FHRS
